Responding to child and adolescent‐to‐parent violence and abuse from a distance: Remote delivery of interventions during Covid‐19

por Rutter, Nikki, Hall, Kirsten, Westmarland, Nicole
Publicado 2022

Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas – A nationwide population-based study

por Berner, Kjetil, Johannesen, Tom Børge, Hall, Kirsten Sundby, Bruland, Øyvind S.
Publicado 2018

Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission

por Fauske, Lena, Hompland, Ivar, Lorem, Geir, Hall, Kirsten Sundby, Bondevik, Hilde
Publicado 2020

The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review

por König, Marton, Osnes, Terje, Bruland, Øyvind, Sundby Hall, Kirsten, Bratland, Åse, Meling, Torstein R.
Publicado 2020

Prognostic Factors and Treatment Results of High-Grade Osteosarcoma in Norway: A Scope Beyond the “Classical” Patient

por Berner, Kjetil, Hall, Kirsten Sundby, Monge, Odd R., Weedon-Fekjær, Harald, Zaikova, Olga, Bruland, Øyvind S.
Publicado 2015

Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature

por Varghese, Mercy, Bruland, Oyvind, Wiedswang, Anne Marit, Lobmaier, Ingvild, Røsok, Bård, Benjamin, Robert S., Hall, Kirsten Sundby
Publicado 2016

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1

por Kolberg, Matthias, Høland, Maren, Ågesen, Trude H., Brekke, Helge R., Liestøl, Knut, Hall, Kirsten S., Mertens, Fredrik, Picci, Piero, Smeland, Sigbjørn, Lothe, Ragnhild A.
Publicado 2013

SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour

por Pulkka, Olli-Pekka, Nilsson, Bengt, Sarlomo-Rikala, Maarit, Reichardt, Peter, Eriksson, Mikael, Hall, Kirsten Sundby, Wardelmann, Eva, Vehtari, Aki, Joensuu, Heikki, Sihto, Harri
Publicado 2017

Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study

por Hall, Kirsten Sundby, Bruland, Øyvind S., Bjerkehagen, Bodil, Lidbrink, Elisabet, Jebsen, Nina, Hagberg, Hans, Papworth, Karin, Hagberg, Oskar, Trovik, Clement, Bauer, Henrik, Eriksson, Mikael
Publicado 2020

Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years

por Smeland, Sigbjørn, Bruland, Øyvind S, Hjorth, Lars, Brosjö, Otte, Bjerkehagen, Bodil, Österlundh, Gustaf, Jakobson, Åke, Hall, Kirsten Sundby, Monge, Odd R, Björk, Olle, Alvegaard, Thor A
Publicado 2011

Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin

por Fløisand, Yngvar, Beiske, Klaus, Tjønnfjord, Geir Erland, Heldal, Dag, Bjerkehagen, Bodil, Revheim, Mona-Elisabeth, Heim, Sverre, Bruland, Øyvind Sverre, Hall, Kirsten Sundby, Tierens, Anne, Delabie, Jan
Publicado 2013

Fibrinogen‐like protein 2 in gastrointestinal stromal tumour

por Pulkka, Olli‐Pekka, Viisanen, Leevi, Tynninen, Olli, Laaksonen, Maria, Reichardt, Peter, Reichardt, Annette, Eriksson, Mikael, Hall, Kirsten Sundby, Wardelmann, Eva, Nilsson, Bengt, Sihto, Harri, Joensuu, Heikki
Publicado 2022

Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours – A prognostic test after surgical resection

por Kolberg, Matthias, Høland, Maren, Lind, Guro E., Ågesen, Trude H., Skotheim, Rolf I., Sundby Hall, Kirsten, Mandahl, Nils, Smeland, Sigbjørn, Mertens, Fredrik, Davidson, Ben, Lothe, Ragnhild A.
Publicado 2015

Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis

por Danielsen, Stine A., Lind, Guro E., Kolberg, Matthias, Høland, Maren, Bjerkehagen, Bodil, Sundby Hall, Kirsten, van den Berg, Eva, Mertens, Fredrik, Smeland, Sigbjørn, Picci, Piero, Lothe, Ragnhild A.
Publicado 2015

Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment

por Ihle, Michaela Angelika, Huss, Sebastian, Jeske, Wiebke, Hartmann, Wolfgang, Merkelbach-Bruse, Sabine, Schildhaus, Hans-Ulrich, Büttner, Reinhard, Sihto, Harri, Sundby Hall, Kirsten, Eriksson, Mikael, Reichardt, Peter, Joensuu, Heikki, Wardelmann, Eva
Publicado 2018

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

por Joensuu, Heikki, Wardelmann, Eva, Eriksson, Mikael, Reichardt, Annette, Hall, Kirsten Sundby, Schütte, Jochen, Cameron, Silke, Hohenberger, Peter, Sihto, Harri, Jost, Philipp J., Lindner, Lars H., Bauer, Sebastian, Nilsson, Bengt, Kallio, Raija, Pesonen, Tommi, Reichardt, Peter
Publicado 2023

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

por Boye, Kjetil, Longhi, Alessandra, Guren, Tormod, Lorenz, Susanne, Næss, Stine, Pierini, Michela, Taksdal, Ingeborg, Lobmaier, Ingvild, Cesari, Marilena, Paioli, Anna, Løndalen, Ayca M., Setola, Elisabetta, Hompland, Ivar, Meza-Zepeda, Leonardo A., Sundby Hall, Kirsten, Palmerini, Emanuela
Publicado 2021

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

por Joensuu, Heikki, Eriksson, Mikael, Hall, Kirsten Sundby, Hartmann, Jörg T, Pink, Daniel, Schütte, Jochen, Ramadori, Giuliano, Hohenberger, Peter, Duyster, Justus, Al-Batran, Salah-Eddin, Schlemmer, Marcus, Bauer, Sebastian, Wardelmann, Eva, Sarlomo-Rikala, Maarit, Nilsson, Bengt, Sihto, Harri, Ballman, Karla V, Leinonen, Mika, DeMatteo, Ronald P, Reichardt, Peter
Publicado 2014

The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma

por Trovik, Clement, Bauer, Henrik C F, Styring, Emelie, Sundby Hall, Kirsten, Vult Von Steyern, Fredrik, Eriksson, Sigvard, Johansson, Ingela, Sampo, Mika, Laitinen, Minna, Kalén, Anders, Jónsson, Halldór, Jebsen, Nina, Eriksson, Mikael, Tukiainen, Erkki, Wall, Najme, Zaikova, Olga, Sigurðsson, Helgi, Lehtinen, Tuula, Bjerkehagen, Bodil, Skorpil, Mikael, Egil Eide, Geir, Johansson, Elisabeth, Alvegard, Thor A
Publicado 2017

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologi...

por Bielack, Stefan S., Smeland, Sigbjørn, Whelan, Jeremy S., Marina, Neyssa, Jovic, Gordana, Hook, Jane M., Krailo, Mark D., Gebhardt, Mark, Pápai, Zsuzsanna, Meyer, James, Nadel, Helen, Randall, R. Lor, Deffenbaugh, Claudia, Nagarajan, Rajaram, Brennan, Bernadette, Letson, G. Douglas, Teot, Lisa A., Goorin, Allen, Baumhoer, Daniel, Kager, Leo, Werner, Mathias, Lau, Ching C., Sundby Hall, Kirsten, Gelderblom, Hans, Meyers, Paul, Gorlick, Richard, Windhager, Reinhard, Helmke, Knut, Eriksson, Mikael, Hoogerbrugge, Peter M., Schomberg, Paula, Tunn, Per-Ulf, Kühne, Thomas, Jürgens, Heribert, van den Berg, Henk, Böhling, Tom, Picton, Susan, Renard, Marleen, Reichardt, Peter, Gerss, Joachim, Butterfass-Bahloul, Trude, Morris, Carol, Hogendoorn, Pancras C.W., Seddon, Beatrice, Calaminus, Gabriele, Michelagnoli, Maria, Dhooge, Catharina, Sydes, Matthew R., Bernstein, Mark
Publicado 2015